A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection

Surgery (United States)

Volumn 157, Issue 4, 2015, Pages 699-707

  Toyoda, Hidenori ^a   Kumada, Takashi ^a   Tada, Toshifumi ^a   Kaneoka, Yuji ^a   Maeda, Atsuyuki ^a  

^a OGAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; TUMOR MARKER; BIOLOGICAL MARKER;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CHILD PUGH SCORE; FEMALE; FIB 4 INDEX; HUMAN; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RATING SCALE; SURVIVAL RATE; THROMBOCYTE COUNT; TREATMENT OUTCOME; AGE; BLOOD; CARCINOMA, HEPATOCELLULAR; COMPLICATION; DECISION SUPPORT SYSTEM; EVALUATION STUDY; LIVER CIRRHOSIS; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SURVIVAL; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; DECISION SUPPORT TECHNIQUES; FEMALE; HEPATECTOMY; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PLATELET COUNT; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84925355472     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2014.10.022     Document Type: Article

References (31)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. H.B. El-Serag, J.A. Davila, N.J. Petersen, and K.A. McGlynn The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update Ann Intern Med 139 2003 817 823
3. H.B. El-Serag, and A.C. Mason Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 1999 745 750
4. T. Umemura, and K. Kiyosawa Epidemiology of hepatocellular carcinoma in Japan Hepatol Res 37 2007 S95 100
5. H. Yoshida, Y. Shiratori, and M. Moriyama Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan Ann Intern Med 131 1999 174 181
6. S. Ko, H. Kanehiro, M. Hisanaga, M. Nagao, N. Ikeda, and Y. Nakajima Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma Br J Surg 89 2002 57 62
7. P. Gassmann, T. Spieker, J. Haier, F. Schmidt, W.A. Mardin, and N. Senninger Prognostic impact of underlying liver fibrosis and cirrhosis after curative resection of hepatocellular carcinoma World J Surg 34 2010 2442 2451
8. M. Kaibori, S. Kubo, and H. Nagano Clinicopathological features of recurrence in patients after 10-year disease-free survival following curative hepatic resection of hepatocellular carcinoma World J Surg 37 2013 820 828
9. R.K. Sterling, E. Lissen, and N. Clumeck Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection Hepatology 43 2006 1317 1325
10. C.T. Wai, J.K. Greenson, and R.J. Fontana A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 2003 518 526
11. G. Sebastiani, A. Vario, and M. Guido Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C J Hepatol 44 2006 686 693
12. A. Vallet-Pichard, V. Mallet, and B. Nalpas FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and FibroTest Hepatology 46 2007 32 36
13. G. Xiao, J. Yang, and L. Yan Comparisons of diagnostic accuracy of APRI and FIB-4 for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systematic review and meta-analysis Hepatology 2014 Aug 18 [Epub ahead of print]
14. Y. Sumida, M. Yoneda, and H. Hyogo Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population BMC Gastroenterol 12 2012 2
15. N. Kokudo, and M. Makuuchi Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: J-HCC guidelines J Gastroenterol 44 2009 S119 S121
16. H. Oka, A. Tamori, T. Kuroki, K. Kobayashi, and S. Yamamoto Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma Hepatology 19 1994 61 66
17. K. Shimizu, T. Taniichi, S. Satomura, S. Matsuura, H. Taga, and K. Taketa Establishment of assay kits for determination of microheterogeneities of alpha-fetoprotein using lectin-affinity electrophoresis Clin Chim Acta 214 1993 3 12
18. H. Okuda, T. Nakanishi, and K. Takatsu Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathological features of solitary hepatocellular carcinoma Cancer 88 2000 544 549
19. E.L. Kaplan, and P. Meier Non parametric estimation for incomplete observation J Am Stat Assoc 53 1958 457 481
20. R. Petro, and M.C. Pike Conservation of the approximation (0-E2)/E in the log rank test for survival data on tumor incidence data Biometrics 29 1973 579 584
21. D. Cox Regression models and life tables J R Stat Soc 34 1972 187 220
22. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C Hepatology 20 1994 15 20
23. R.N. Pugh, I.M. Murray-Lyon, J.L. Dawson, M.C. Pietroni, and R. Williams Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 1973 646 649
24. The Cancer of the Liver Italian Program (CLIP) Investigators A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients Hepatology 28 1998 751 755
25. M. Kudo, H. Chung, and S. Haji Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score Hepatology 40 2004 1396 1405
26. H. Toyoda, T. Kumada, T. Tada, Y. Sone, Y. Kaneoka, and A. Maeda Characteristics and prognosis of patients with hepatocellular carcinoma after the year 2000 in Japan J Gastroenterol Hepatol 26 2011 1765 1771
27. H. Toyoda, T. Kumada, and S. Kiriyama Impact of surveillance on survival of patients with initial hepatocellular carcinoma: a study from Japan Clin Gastroenterol Hepatol 4 2006 1170 1176
28. Y. Aoyagi, O. Isokawa, T. Suda, M. Watanabe, Y. Suzuki, and H. Asakura The fucosylation index of alpha-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma Cancer 83 1998 2076 2082
29. Y. Koike, Y. Shiratori, and S. Sato Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients Cancer 91 2001 561 569
30. N. Tamaki, M. Kurosaki, and S. Matsuda Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients J Gastroenterol 49 2014 1495 1503
31. I. Ikai, M. Kudo, and S. Arii Report of the 18th follow-up survey of primary liver cancer in Japan Hepatol Res 40 2010 1043 1059